Jose-Armando Fuentes

• Led the global repositioning and lifecycle management of Roche Open Molecular Systems, achieving worldwide sales of +250 MCHF
• Oversaw the launch of Roche Digital PCR (dPCR) and NextGen PCR systems, with annual sales of $10M and $50M, respectively
• Directed product development and commercial strategy for Nucleic Acid Purification solutions (NAP) and Digital LightMix assays
• Served as a core member of Roche's AI implementation squad for business optimization in planning, forecasting, and marketing
• Managed global M&D, R&D, and Product Care budgets, totaling +12 MCHF

• Executed lifecycle plans for NAP & qPCR systems, driving WW sales of +100 MCHF, and Roche's life sciences portfolio, totaling +50 MCHF
• Directed supply and allocation strategies for PCR products during COVID-19, ensuring global availability
• Established partnerships with multinationals and CROs to validate dPCR assays, extending Roche's diagnostics reach
• Led strategy redefinition for the oncology portfolio, impacting markets in the US, China, Western Europe, and emerging markets

• Restructured the Marketing & Business Development division, enhancing ROI and accelerating a 3-year pipeline
• Directed market access, pricing, and lifecycle strategies, securing +100 MUSD in revenue and alliances with Roche Pharma
• Expanded public healthcare programs and Roche's pathology-lab network, supporting HPV, OAC, HER2, ALK, and PDL1 diagnostics

• Led strategic planning, medical value, and market access for Roche's diagnostics division
• Secured alliances with Roche Pharma, Gilead, and Ferring, driving a pipeline of nonorganic opportunities
• Negotiated a 3-year sourcing agreement with DiaSorin to serve Latin America's largest plasma facility, adding +19 MUSD in sales

• Developed marketing strategy for Pfizer's top-selling vaccines portfolio, achieving +90 MUSD in annual revenue
• Launched a pneumococcal vaccine for individuals over 50 and executed a high-ROI risk-sharing initiative awarded by Pfizer
• Managed lifecycle and in-licensing projects for respiratory therapies, adding long-term portfolio value

• Defined Pfizer Mexico's strategic plan and business alignment, focusing on 2010-2015 growth
• Proposed in/out-licensing and acquisition projects, expanding Pfizer's generics and established brands

• Coordinated Pfizer-Wyeth integration for the Women's Health portfolio in collaboration with Boston Consulting Group
• Integrated CV/Metabolic 5-year strategy for Pfizer products across Latin America, the Middle East, and Asia

Pfizer

• Consultancy & Market Research: Led market intelligence for oncology, HIV, and ID portfolios, providing strategic insights for product launches & lifecycle management.

El Palacio de Hierro

• E-Commerce & New Business: Redesigned & established profitable Travel Services and Advertising units, transforming cost centers into revenue streams.

Walter Landor

• Branding Consultancy: Contributed as an analyst in consultancy projects across Mexico, the USA, and Central America.